Perceptronix Brings Early Lung Cancer Detection to UK By Signing Service Agreement With University Hospital of Coventry and Warwickshire NHS Trust
Perceptronix Medical Inc. (”Perceptronix”) announced it has signed a service agreement for its LungSign(TM) test (formerly ClearSign(TM)) with University Hospital of Coventry and Warwickshire (UHCW) NHS Trust in the UK.
This entry was posted on Tuesday, May 29th, 2007 at 9:58 am and is filed under Research, Early Detection. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.